Hayder Saeed MD

Hematology•Tampa, FL

Hematologic Oncology

Associate Member

Request appointment

12902 Magnolia Dr.Tampa, FL 33612
Book by Phone+1(507) 708-7488
Fax+1 813-745-3875

Overview of Dr. Saeed

Dr. Hayder Saeed is a hematologist specializing in hematologic oncology, currently based in Tampa, FL. He completed his fellowship in Hematology and Medical Oncology at the University of Kentucky College of Medicine and has held multiple academic positions, including an Associate Member at H. Lee Moffitt Cancer Center and an Associate Professor at the University of South Florida. His experience spans neuro-oncology, amyloidosis, hematologic oncology, breast cancer, and platelet disorders. Notably, he has contributed several publications on lymphoma, Hodgkin's lymphoma, and related therapies. Dr. Saeed has been involved in clinical trials and has received honors such as the AACR/ASCO Clinical trial workshop participation and a Letter of Achievement from UK’s hematology oncology fellowship program.

Education & Training

University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Kentucky College of MedicineResidency, Internal Medicine, 2010 - 2013
University of Baghdad College of MedicineClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2019 - 2027
KY State Medical License 2013 - 2027
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

AACR/ASCO Clinical trial workshop in Vail,CO AACR/ASCO, 2016
CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016
CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2016

Clinical Trials

Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma Start of enrollment: 2018 Dec 19
COMPLETED
PHASE1

Publications & Presentations

PubMed

A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell Lymphoma.
Hayder Saeed, Melanie Mediavilla Varela, Eva Sahakian, Mahrukh Naqvi, Qianxing Mo
Hematological Oncology. 2026-09-01
Mogamulizumab for adult T-cell leukemia/lymphoma: a literature review.
Can Jones, Jun Chih Wang, Hayder Saeed
Translational Cancer Research. 2026-05-30
10 citations
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025.
Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis
Journal of the National Comprehensive Cancer Network. 2025-10-01

Journal Articles

Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆
Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect

Abstracts/Posters

Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-R
Hayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Use of Lenalidomide Plus Rituximab in TP53-Mutated Mantle Cell Lymphoma (MCL) Outside of Clinic Trial: The Moffitt Experience
Hayder Saeed, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Authored Content

Unleashing the Spark: My Top #ASH23 Posts That Ignited EngagementDecember 2023
Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?December 2022
An Update on T Cell Lymphoma from SOHO 2021September 2021